KC

Kartik Chandra Behera

Active Director Director DIN 09748593
DIN 09748593 First appointment Sep 2022 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Kartik Chandra Behera

Data last updated:

Kartik Chandra Behera is a Director at Sanguine Multitrade Private Limited (since 2022). The company operates in Business Services.

DIN 09748593
Primary Designation Director
Industry Business Services
First Appointment 26 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sanguine Multitrade Private Limited U74999OR2022PTC040859
Director26 Sep 20222022Active

Board colleagues of Kartik Chandra Behera

NameDINCompanyDesignation
Rajesh Kumar Panda09748572Sanguine Multitrade Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sanguine Multitrade Private Limited
Premium access

Shareholding and investment profile for Kartik Chandra Behera

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kartik Chandra Behera

Kartik Chandra Behera currently holds 1 directorship: Sanguine Multitrade Private Limited (Director, since 26 Sep 2022).

Kartik Chandra Behera was first appointed on 26 Sep 2022 as Director at Sanguine Multitrade Private Limited.

The current boards of Kartik Chandra Behera's companies include Rajesh Kumar Panda (Sanguine Multitrade Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available